BIONOMOUS announces today it has raised a USD 2.7 million Series A funding round led by Nivalis Group, with participation from Cybernetix Ventures and Capital Risque Fribourg.
Since we founded Bionomous in 2019 it has been a challenging and exciting pathway to get where we are today. The closing of this Series A funding round is a huge milestone for our company. This investment allows us to scale the production of the EggSorter and prepare for global deployment.
The investment round is led by Nivalis Group, a Swiss Holding based in Villaz-St-Pierre, with participation from Cybernetix Ventures, a leading robotics-focused US venture capital firm based in the Boston, and Capital Risque Fribourg, an early-stage investment company based in Fribourg. Fady Saad, Cybernetix Ventures Founder and Managing Partner, will join Bionomous board of directors.
Frank Bonnet, Bionomous CEO & co-founder explains:
Nivalis Group President, Christophe Fragnière about this new investment :
For Cybernetix Ventures, the reasons to invest are clear:
We believe that this milestone would not have been possible without the amazing team that we have. Over the past year, we concentrated our efforts on optimizing the EggSorter based on the feedback received from early adopters. And, our new device obtained CE certification in December 2022 and is now ready to be deployed on the market.
We are starting now the commercialization phase of the EggSorter, with customers already in Europe, USA, and China, and this Series A funding is key to scale the production and to start expanding our sales globally.
Read the official press release below.